Paola Maria Manzini, MD, holds board certification in Gastroenterology and Digestive Endoscopy in 1993 at the Modena University School of Medicine and in Haematology in 1999 at the Turin University School of Medicine. She graduated in 1989 at medical school in the Turin University School of Medicine, . She was awarded a training (1994-1995) at Prof. J.Dusheiko University Department of Medicine of the Royal Free Hospital in London (U.K.) on hepatitis C virus and lipoproteins. She has been a consultant in the Blood bank of AOU Città della Salute e della Scienza di Torino since March 1995 where she oversaw the blood born infectious disease and the clinic for iron overload. She is currently responsible for Immunohaematology Laboratory, coordinator of the Maxi Emergency Event Plans, for Patient Blood Management programs and she is part of the PaBloE, an European Blood Alliance project focused on PBMe. She is the Chief of Regional (Piemonte and Valle d’Aosta) Coordination Centre for Porphyrias. Since May 2019 she is part of the International Editorial Board of the Journal “Blood Transfusion”. Since 2019 she is Associate Professor of Immunohematology in the University of Torino. She was the Principal Investigator for the Randomized Controlled trial PLACO COVID (ClinicalTrials.gov: NCT04428021) about efficacy of Covid-19 Convalescent Plasma in the treatment of hospitalized Covid-19 patients. She has numerous scientific publications in international medical journals.